Nova Science Publishers now introduce an interesting book on
research to help reduce global tobacco-related diseases in four
volumes. Volume One describes general topics on nicotinism and the
emerging role of electronic cigarettes; Volume Two describes basic
molecular biology of nicotinism; Volume Three describes emerging
biotechnology in nicotinism; and Volume Four describes chronic
diseases associated with nicotinism and
disease-specific-spatiotemporal (DSST) charnolosomics and
charnolopharmacotherapeutics for the targeted, safe and effective
personalized theranostics of nicotinism. This book is written
primarily for readers interested in learning more about the basic
molecular biology, recent biotechnology, and molecular genetics for
diseases linked to nicotinism as well as their possible prevention
and cure. A novel disease-specific spatiotemporal charnolosomics
along with conventional omics (genomics, proteomics, metabolomics,
lipidomics, and metallomics) with correlative and combinatorial
bioinformatic analysis is proposed for the first time to accomplish
targeted, safe, and effective personalized theranostics of
nicotinism for a better quality of life. This book is written
primarily for the health and well-being of highly vulnerable
adolescents, who engage in drug seeking behavior (particularly
tobacco and alcohol), become victims of chronic addiction, and
suffer from poor quality of life, early morbidity, and mortality.
Moreover, nicotine exposure during intrauterine life can induce
diversified embryopathies (such as abortion, stillbirth, sudden
infant death syndrome, microcephaly, craniofacial abnormalities,
growth retardation, ADHD, autism, and craniofacial abnormalities)
in developing infants; likewise, asthma, COPD, cancer, and
infertility occurs in adults. The primary goal is to minimize
nicotine-induced early morbidity and mortality due to asthma,
emphysema, cancer, heart attack, diabetes, obesity, infertility,
major depressive disorders, schizophrenia, Alzheimers disease, and
several other neurological and neuropsychiatric disorders, which
are elegantly described in this book. Volume Two describes the
basic molecular biology of nicotinism in two sections. Section One
(Concepts & Mechanism) consists of seven chapters, while
Section Two (Clinical Management of Nicotinism) consists of two
chapters. While each volume will serve as a textbook for biomedical
students and as a reference book for researchers, scientists,
doctors, and professors, all four of the volumes systematically
will certainly enhance the existing knowledge and wisdom regarding
nicotinism and drug addiction in general. It is envisaged that
readers (researchers, doctors, nurses, teachers, students
(particularly high school and college students) and the general
public will enjoy learning the most recent and novel personalized
theranostic approaches currently being implemented in this
clinically-significant discipline by carefully going through the
most interesting and thought-provoking contents of this book.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!